Naoki Kawagishi
Hokkaido University(JP)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Hepatocellular Carcinoma Treatment and Prognosis, Hepatitis B Virus Studies, Systemic Lupus Erythematosus Research
Most-Cited Works
- → L‐Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis(2018)85 cited
- → Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1–3 signaling, but not FGFR4 signaling(2020)74 cited
- → Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis(2018)54 cited
- → Attenuation of Cross-Talk Between the Complement and Coagulation Cascades by C5a Blockade Improves Early Outcomes After Intraportal Islet Transplantation(2010)52 cited
- → Comparing the risk of hepatitis B virus reactivation between direct‐acting antiviral therapies and interferon‐based therapies for hepatitis C(2017)45 cited
- → Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria(2020)44 cited
- → Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy‐associated hepatitis in Japan(2020)43 cited
- → Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real‐world setting(2019)43 cited
- → Entecavir treatment of hepatitis B virus‐infected patients with severe renal impairment and those on hemodialysis(2019)42 cited
- → Analysis of the optimal psoas muscle mass index cut‐off values, as measured by computed tomography, for the diagnosis of loss of skeletal muscle mass in Japanese people(2020)42 cited